Easy Access IP: ahead of the game or easy way out? C. Simone Fishburn BriefCommunication Pages: 303 - 303
Chemokine CXC motif ligand 10 (CXCL10; IP-10); CXC chemokine receptor 3 (CXCR3) BriefCommunication Pages: 306 - 306
Spleen tyrosine kinase (SYK); FMS-like tyrosine kinase 3 (FLT3; CD135) BriefCommunication Pages: 308 - 308
CpG island methylation; polycomb repressive complex 2 (PRC2); enhancer of zeste homolog 2 (EZH2) BriefCommunication Pages: 309 - 309
TANK-binding kinase 1 (TBK1); inhibitor of κ-light polypeptide gene enhanced in B cells kinase-ε (IKBKE; IKK-i); HER2 (EGFR2; ErbB2; neu) BriefCommunication Pages: 310 - 310
TANK-binding kinase 1 (TBK1); inhibitor of κ-light polypeptide gene enhancer in B cells kinase-ε (IKBKE; IKK-i); Janus kinase-1 (JAK-1); JAK-2; K-Ras (KRAS) BriefCommunication Pages: 313 - 313
Solute carrier family 1 glial high affinity glutamate transporter member 2 (SLC1A2; EAAT2; GLT-1) BriefCommunication Pages: 318 - 318
Transient receptor potential cation channel subfamily C member 4 (TRPC4) BriefCommunication Pages: 319 - 319
Plasma lipid signature to identify presymptomatic individuals that may progress to Alzheimer's disease (AD) BriefCommunication Pages: 323 - 323
Telomerase promoter activity–based assay to detect circulating tumor cells (CTCs) BriefCommunication Pages: 324 - 324
A hepatoma-based cell culture model that supports the entire cycle of HBV and HCV BriefCommunication Pages: 325 - 325
Bispecific, diagnostic antibodies for enhanced detection of dimerized or phosphorylated oncoproteins BriefCommunication Pages: 326 - 326
Induced multipotent progenitor cell–derived human hepatocytes (iMPC-Heps) with proliferative and functional potential in vivo BriefCommunication Pages: 327 - 327
Müller glia cells as a source for regenerative retinal neuronal cell types BriefCommunication Pages: 328 - 328
Cerebrospinal fluid (CSF) levels of soluble CD19 to detect CNS disease in patients with lymphoma BriefCommunication Pages: 329 - 329
Circulating giant macrophages as diagnostic markers for metastasizing tumors BriefCommunication Pages: 330 - 330